Phalanx Biotech Group, a provider of genomic products and services, has introduced microRNA Microarray - miRBase v17.
The miRBase consists of 2,406 additional mature microRNA of which 563 represent newly verified sequences in human, mouse and rats.
Phalanx Biotech’s arrays are manufactured using proprietary PhalanxJet spotting technology, specialized coating chemistry and an automated assembly system.
Phalanx Biotech Group Product Development head Richard Su said this microRNA features a new hybridization chemistry enabling greater microarray signal intensities at reduced sample input.
"Furthermore, as our whole genome gene expression microarray product line expands, we anticipate a set of complementary microRNA microarrays to offer researchers the capability to conduct gene and microRNA expression profiling studies in parallel," Su said.